Primary Peritoneal Carcinoma Completed Phase 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00011986Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerTreatment